EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CiThroModel Improves Prediction of Symptomatic Venous Thromboembolism in Hospitalized Patients With Cirrhosis Without Hepatocellular Carcinoma

Alberto Zanetto iD, Alessandro Vitale, Filippo Pelizzaro, Vittorio Simeon, Elena Campello, Laura Turco iD, Lorenz Balcar iD, Francesco Paolo Russo, Patrizia Burra iD, Paolo Simioni, Marco Senzolo

United European Gastroenterology Journal · 2025

DOI: 10.1002/ueg2.12758 ↗

Kurz gefasst

Fachartikel in der Zeitschrift United European Gastroenterology Journal, 2025. Verfasst von Alberto Zanetto und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy. Hauptthemen laut MEDLINE: Liver Cirrhosis, Venous Thromboembolism. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & Aims Venous thromboembolism (VTE) is a recognized complication of acutely ill patients, but its incidence and risk factors in those with cirrhosis are uncertain.

Methods

We retrospectively studied a consecutive cohort of cirrhosis patients non‐electively admitted to our medical unit to determine the rates of symptomatic VTE during hospitalization. Firstly, we explored associations with baseline, clinical and laboratory characteristics using logistic regression. Secondly, we developed a clinical prediction model that could predict the risk of in‐hospital VTE.

Results

We included 687 patients (median age 61 years old; 68% male; Child–Pugh A/B/C, 13%/40%/47%). During hospitalization, 34 patients (4.9%) experienced VTE. Multivariate analysis showed that male sex (OR: 2.56, p = 0.05), AKI (OR: 3.1, p = 0.001), bacterial infections (OR: 2.6, p = 0.008), Pugh score (OR: 1.6. p < 0.001), family history of thrombosis (OR: 3.1, p = 0.04), reduced mobility (OR: 4.6, p < 0.001), and C‐reactive protein (OR: 1.1, p = 0.005) were independent predictors of VTE. We combined these variables in a prediction model ( Ci rrhosis Thro mbosis Model ) that accurately discriminated between high‐ and low‐risk patients. The AUROC of CiThroModel was significantly higher than that of Padua prediction score (0.882 vs. 0.742). After validating the CiThroModel using bootstrapping, the adjusted model maintained optimal discrimination ability (0.862) and calibration. The adjusted formula to calculate the in‐hospital risk of VTE was −9.00 + 0.82 [Male sex] + 1.14 [AKI] + 0.98 [Infection] + 0.48 * Child Pugh score + 1.14 [VTE family history] + 1.54 [Reduced mobility] + 0.15 * PCR/10.

Conclusion

The CiThroModel seems a valuable tool for identifying hospitalized patients with cirrhosis at risk of VTE ( https://majinzin.shinyapps.io/vterisk/ ).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisVenous ThromboembolismHumansMaleFemaleMiddle AgedRetrospective StudiesRisk FactorsHospitalizationAgedRisk AssessmentCarcinoma, HepatocellularIncidencePredictive Value of TestsLiver Neoplasms

Stichwörter der Autor:innen

CiThroModelheopatocellular carcinomaliver cirrhosisvenous thromboembolism

Autor:innen und Institutionen

  • Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.
  • Gastroenterology and Multivisceral Transplant Unit, Padova University Hospital, Padova, Italy.
  • Hepatobiliary Surgery and Liver Transplantation Unit, Padova University Hospital, Padova, Italy.
  • Medical Statistics Unit, University "Luigi Vanvitelli", Naples, Italy.
  • Department of Medicine (DIMED), University of Padova, Padova, Italy.
  • First Chair of Internal Medicine and Thrombotic and Haemorrhagic Disease Unit, Padova University Hospital, Padova, Italy.

ORCID-Profile: Alberto Zanetto, Laura Turco, Lorenz Balcar, Patrizia Burra

Zitieren

APA

Zanetto, A., Vitale, A., Pelizzaro, F., Simeon, V., Campello, E., Turco, L., Balcar, L., Russo, F. P., Burra, P., Simioni, P., & Senzolo, M. (2025). CiThroModel Improves Prediction of Symptomatic Venous Thromboembolism in Hospitalized Patients With Cirrhosis Without Hepatocellular Carcinoma. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.12758

Vancouver

Zanetto A, Vitale A, Pelizzaro F, Simeon V, Campello E, Turco L, et al. CiThroModel Improves Prediction of Symptomatic Venous Thromboembolism in Hospitalized Patients With Cirrhosis Without Hepatocellular Carcinoma. United European Gastroenterology Journal. 2025. doi:10.1002/ueg2.12758

BibTeX
@article{Zanetto2025,
  author = {Zanetto, Alberto and Vitale, Alessandro and Pelizzaro, Filippo and Simeon, Vittorio and Campello, Elena and Turco, Laura and Balcar, Lorenz and Russo, Francesco Paolo and Burra, Patrizia and Simioni, Paolo and Senzolo, Marco},
  title = {CiThroModel Improves Prediction of Symptomatic Venous Thromboembolism in Hospitalized Patients With Cirrhosis Without Hepatocellular Carcinoma},
  journal = {United European Gastroenterology Journal},
  year = {2025},
  doi = {10.1002/ueg2.12758}
}
Kostenlos starten →